AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Nexien BioPharma, Inc.

$0.00 +$0.00 (+0.00%)
OTC · 30 Oct 2026 20:00 UTC
Previous Close
$0.00
Day Range
$0.00$0.00
Year Range
$0.00$0.00
Market Cap
7.08K
AVG Volume
332
Trailing/Forward PE
-0.03/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Net Income (USD) · A
-25B025B50B75B100B201620172018201920202021202220232024
NXEN Net Income (USD) by year
PeriodNet Income (USD)
2024-239.11K
202382.25B
2022-626K
2021-1.86M
2020-2.67M
2019-4.3M
2018-1.28M
2017-83.62K
2016-20.99K
Operating Income (USD) · A
-4M-3M-2M-1M0201620172018201920202021202220232024
NXEN Operating Income (USD) by year
PeriodOperating Income (USD)
2024-155.66K
2023-282.61K
2022-563.15K
2021-2.12M
2020-2.6M
2019-3.93M
2018-1.28M
2017-268.77K
2016-19.73K
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: NXEN

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one.

Nexien BioPharma, Inc.
NXEN
Stockpicker

Video analysis: NXEN

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: NXEN

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.